Juno Looks To Shore Up Canada Supply Chains With Omega Deal
Juno Expects To Bring Over 100 New Products To The Canadian Market
Quickfire M&A has been unveiled in Canada, with Juno Pharmaceuticals taking control of the former Nichi-Iko affiliate Omega Laboratories.
You may also be interested in...
Hikma Expands In Canada With Four New Injectables
Hikma has bolstered its generic sterile injectables business in Canada with four new launches.
Hikma Buys Teligent Assets To Expand Into Canada
Hikma has snapped up the Canadian sterile injectables assets of bankrupt Teligent in a $46m deal that marks Hikma’s first move into Canada.
Nichi-Iko Buys Sagent To Strengthen US Biosimilars Presence
Nichi-Iko Pharmaceutical Co. Ltd. will pay $736m in cash for Sagent Pharmaceuticals Inc. in a deal that will further expand the Japanese company's biosimilars business beyond Asia and diversify the US generics firm's injectable medicines portfolio.